Literature DB >> 1605426

The clinical course of idiopathic dilated cardiomyopathy. A population-based study.

D D Sugrue1, R J Rodeheffer, M B Codd, D J Ballard, V Fuster, B J Gersh.   

Abstract

OBJECTIVE: To describe the prognosis of individuals with idiopathic dilated cardiomyopathy in a population-based sample and to compare this with the prognosis of patients in a previous referral center case series of idiopathic dilated cardiomyopathy.
DESIGN: Cohort study.
SETTING: Population-based in Olmsted County, Minnesota. PATIENTS: Forty residents of Olmsted County, Minnesota with idiopathic dilated cardiomyopathy initially diagnosed between 1975 and 1984 who were followed through 1 July 1989 and 104 patients from a Mayo Clinic referral case series from 1960 to 1973. MEASUREMENTS: Survival for the population-based cohort at 1 year and 5 years.
RESULTS: Survival at 1 year differed dramatically between the population-based cohort and the referral case series at 1 year (95% compared with 69%, respectively) and at 5 years (80% compared with 36%, respectively) (P less than 0.001). Long-term survival for the population-based cohort was nonetheless impaired when compared with an age- and sex-matched cohort, that is, the 1980 Minnesota white population (8-year survival: observed, 58% compared with expected, 83%; P less than 0.001). Among community patients, older age (adjusted Cox model hazard ratio for 10-year increase in age, 1.59; 95% CI, 1.08 to 2.35) and lower left ventricular ejection fraction (adjusted hazard ratio for 10% decrease, 1.90; CI, 1.04 to 3.50) were independently associated with impaired survival.
CONCLUSIONS: These population-based data challenge the clinical perception of the clinical course of idiopathic dilated cardiomyopathy based on referral practice prognostic studies and suggest that the clinical course of this condition may be more favorable than previously recognized.

Entities:  

Mesh:

Year:  1992        PMID: 1605426     DOI: 10.7326/0003-4819-117-2-117

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  33 in total

Review 1.  Global improvement in left ventricular performance observed with cardiac contractility modulation is the result of changes in regional contractility.

Authors:  D J Callans; S Fuchs; Y Mika; I Shemer; R Aviv; W Haddad; N Darvish; S A Ben-Haim; R Kornowski
Journal:  Heart Fail Rev       Date:  2001-01       Impact factor: 4.214

Review 2.  Update on implantable cardioverter defibrillator trials.

Authors:  Abrar H Shah; David T Huang; Spencer Z Rosero; James P Daubert
Journal:  Curr Cardiol Rep       Date:  2004-09       Impact factor: 2.931

3.  Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy.

Authors:  Marwan M Refaat; Steven A Lubitz; Seiko Makino; Zahid Islam; J Michael Frangiskakis; Haider Mehdi; Rebecca Gutmann; Michael L Zhang; Heather L Bloom; Calum A MacRae; Samuel C Dudley; Alaa A Shalaby; Raul Weiss; Dennis M McNamara; Barry London; Patrick T Ellinor
Journal:  Heart Rhythm       Date:  2011-10-17       Impact factor: 6.343

4.  Low-dose dobutamine stress echocardiography predicts the improvement of left ventricular systolic function and long-term prognosis in patients with idiopathic dilated cardiomyopathy.

Authors:  Yoshihisa Matsumura; Jun Takata; Hiroaki Kitaoka; Tomoyuki Hamada; Makoto Okawa; Toru Kubo; Yoshinori Doi
Journal:  J Med Ultrason (2001)       Date:  2006-03       Impact factor: 1.314

Review 5.  Sudden cardiac death in patients with congestive heart failure: toward a unified rational treatment approach.

Authors:  D J Callans
Journal:  J Nucl Cardiol       Date:  1998 Jan-Feb       Impact factor: 5.952

6.  Left atrial size is the major predictor of cardiac death and overall clinical outcome in patients with dilated cardiomyopathy: a long-term follow-up study.

Authors:  M G Modena; N Muia; F A Sgura; R Molinari; A Castella; R Rossi
Journal:  Clin Cardiol       Date:  1997-06       Impact factor: 2.882

7.  The zinc containing pro-apoptotic protein siva interacts with the peroxisomal membrane protein pmp22.

Authors:  Matthias Nestler; Ulrike Martin; Peter Hortschansky; Hans-Peter Saluz; Andreas Henke; Thomas Munder
Journal:  Mol Cell Biochem       Date:  2006-05-09       Impact factor: 3.396

8.  Absence of viral nucleic acids in early and late dilated cardiomyopathy.

Authors:  N G Mahon; B Zal; G Arno; P Risley; J Pinto-Basto; W J McKenna; M J Davies; C Baboonian
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

9.  Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group.

Authors:  A Di Lenarda; G Secoli; A Perkan; D Gregori; G Lardieri; B Pinamonti; G Sinagra; M Zecchin; F Camerini
Journal:  Br Heart J       Date:  1994-12

10.  Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23.

Authors:  K R Bowles; R Gajarski; P Porter; V Goytia; L Bachinski; R Roberts; R Pignatelli; J A Towbin
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.